go-v.orgdoi

Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China

Yujie Yuan, Jinning Ye, Huizhi Qiu, Shaoqing Niu, Bixiu Wen, Dongping Wang, Xinping Cao, Yufeng Ren · Journal of Cancer · 2017

  • DOI 10.7150/jca.21605
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2017

Abstract

BACKGROUND: Esthesioneuroblastoma (ENB) is an uncommon neoplasm arising from the olfactory mucosa.The optimal treatment regimen for ENB remains unclear.This study aims to evaluate its clinical features, long-term outcomes and explore optimal treatment patterns.METHODS: Clinical data of consecutive 44 ENB patients were reviewed retrospectively.The correlation between clinical features and treatment approaches were analyzed, with several prognostic factors explored meanwhile.

RESULTS:The age of onset of ENB showed a bimodal distribution, with peaks at 10~20 and 50~60 years.The median follow-up time was 84 months (range, 27~198 months).The 5-year overall and progression free survival rates were 42.7% and 39.1%, respectively, with 10-year rates of 28.9% and 21.7% respectively.Overall, 19 patients developed recurrent disease.Patients undergoing surgery combined with adjuvant radiotherapy had significantly higher 5-year overall survival (67.5% vs.

33.3%,P=0.043) and progress-free survival (60.0%vs.18.7%, P=0.008) than those receiving other treatment approaches.No-Skin-involved ENB was associated with markedly better 5-year overall survival (45.5%vs.0%, P=0.038) and progress-free survival (31.3% vs. 0 %, P=0.001) compared with skin-involved tumor.CONCLUSIONS: ENB is a rarely malignant tumor with high probability of locoregional recurrence and poor survival.Surgical resection followed by radiotherapy has been shown to achieve optimal local control and overall survival.

Open the resolved locator · 10.7150/jca.21605

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:29 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v09p0174.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.